HCCC-9810 (人胆管细胞型肝癌细胞) (STR鉴定正确)

一键复制产品信息

参考文献

• The heterogeneity of signaling pathways and drug responses in intrahepatic cholangiocarcinoma with distinct genetic mutations (2024-01-11)

  作者：Yangyang Feng:1.Cancer Center, Faculty of Health Sciences, University of Macau, Macau SAR, China. ; 2.Zhuhai UM Science & Technology Research Institute, Zhuhai, Guangdong, China. ; 3.Centre for Precision Medicine Research and Training, Faculty of Health Sciences, University of Macau, Macau SAR, China. ; Ming Zhao:1.Cancer Center, Faculty of Health Sciences, University of Macau, Macau SAR, China. ; 2.Centre for Precision Medicine Research and Training, Faculty of Health Sciences, University of Macau, Macau SAR, China. ; 3.Department of Gastroenterology, Clinical Medical College and The First Affiliated Hospital of Chengdu Medical College, Chengdu, China. ; Lijian Wang:1.Cancer Center, Faculty of Health Sciences, University of Macau, Macau SAR, China. ; 2.Centre for Precision Medicine Research and Training, Faculty of Health Sciences, University of Macau, Macau SAR, China. ; Ling Li:1.Cancer Center, Faculty of Health Sciences, University of Macau, Macau SAR, China. ; 2.Centre for Prec

  期刊：The heterogeneity of signaling pathways and drug responses in intrahepatic cholangiocarcinoma with distinct genetic mutations

  DOI：10.1038/s41419-023-06406-7

  影响因子 ：9.0

  引用产品： HCCC-9810 细胞

• Protein regulator of cytokinesis 1 accentuates cholangiocarcinoma progression via mTORC1-mediated glycolysis (2024-02-28)

  作者：Chao Zhang:1.Department of Hepatobiliary Surgery, Shandong Provincial Hospital, Shandong University, 324 Jingwuwei 7Th Road, Jinan, 250021, Shandong, People's Republic of China. ; 2.Department of Hepatobiliary Surgery, Linyi People's Hospital, Linyi, 276034, Shandong, People's Republic of China. ; Chengkun Qin:1.Department of Hepatobiliary Surgery, Shandong Provincial Hospital, Shandong University, 324 Jingwuwei 7Th Road, Jinan, 250021, Shandong, People's Republic of China. qinchengkun_slyy@163.com. ;

  期刊：Protein regulator of cytokinesis 1 accentuates cholangiocarcinoma progression via mTORC1-mediated glycolysis

  DOI：10.1007/s13577-024-01032-7

  影响因子 ：4.3

  引用产品： HCCC-9810 细胞 ,  HuCC-T1 细胞 ,  RBE 细胞

• Repression of LSD1/KDM1A activity improves the response of liver cancer cells to the lenvatinib (2024-03-28)

  作者：Yi Zong:1.Department of Radiology, The Fourth Affiliated Hospital Zhejiang University School of Medicine, Yiwu, Zhejiang, China. ; Zhigang Tao:1.Department of Radiology, Hangzhou Cancer Hospital, Hangzhou, Zhejiang, China. ; Siyi Jiang:1.Intensive Care Unit, The Fourth Affiliated Hospital Zhejiang University School of Medicine, Yiwu, Zhejiang, China. ; Minyuan Wang:1.Department of Radiology, The Fourth Affiliated Hospital Zhejiang University School of Medicine, Yiwu, Zhejiang, China. ; Weihua Yu:1.Department of Gastroenterology, The Fourth Affiliated Hospital, Zhejiang University School of Medicine, Yiwu, Zhejiang, China. yuweihua84@zju.edu.cn. ;

  期刊：Repression of LSD1/KDM1A activity improves the response of liver cancer cells to the lenvatinib

  DOI：10.1007/s12672-024-00947-9

  影响因子 ：2.2

  引用产品： HCCC-9810 细胞

• Development of potent antibody drug conjugates against ICAM1+ cancer cells in preclinical models of cholangiocarcinoma (2023-09-16)

  作者：Bing Zhu:1.Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, Zhejiang, 310022, China. ; 2.Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, Zhejiang, 310018, China. ; Xinyan Wang:1.Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, Zhejiang, 310022, China. ; 2.Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, Zhejiang, 310018, China. ; 3.Institute of Molecular Medicine, Hangzhou Institute for Advanced Study (UCAS), Hangzhou, Zhejiang, 310000, China. ; Takaya Shimura:1.Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, Nagoya, 467-8601, Japan. ; Andrew C Huang:1.MabPlex International, Yantai, Shandong, 264006, China. ; Nana Kong:1.MabPlex International, Yantai, Shandong, 264006, China. ; Yujie Dai:1.MabPlex International, Yantai, Shandong, 264006, China

  期刊：Development of potent antibody drug conjugates against ICAM1+ cancer cells in preclinical models of cholangiocarcinoma

  DOI：10.1038/s41698-023-00447-z

  影响因子 ：7.9

  引用产品： HuCC-T1 细胞 ,  HCCC-9810 细胞

• Circ_0020256 induces fibroblast activation to drive cholangiocarcinoma development via recruitment of EIF4A3 protein to stabilize KLF4 mRNA (2023-05-13)

  作者：Zongyan Li:1.Department of Pancreatic Hepatobiliary Surgery, Department of General Surgery, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510650, Guangdong Province, P.R. China. ; Zuxiao Chen:1.Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510260, Guangdong Province, P.R. China. ; Shiying Li:1.Key Laboratory of Molecular Target & Clinical Pharmacology, School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou, 511436, Guangdong Province, P.R. China. ; Xiangjun Qian:1.Department of Pancreatic Hepatobiliary Surgery, Department of General Surgery, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510650, Guangdong Province, P.R. China. ; Lei Zhang:1.Department of Pancreatic Hepatobiliary Surgery, Department of General Surgery, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510650, Guangdong Province, P.R. China. ; Guojie Long:1.Department of Pancre

  期刊：Circ_0020256 induces fibroblast activation to drive cholangiocarcinoma development via recruitment of EIF4A3 protein to stabilize KLF4 mRNA

  DOI：10.1038/s41420-023-01439-5

  影响因子 ：7.0

  引用产品： HCCC-9810 细胞 ,  RBE 细胞

• Oncogenic Role of the NFATC2/NEDD4/FBP1 Axis in Cholangiocarcinoma (2023-06-05)

  作者：Wei Zhao:1.Department of Hepatobiliary and Pancreatic Surgery, the Affiliated Hospital of Qingdao University, Qingdao, China. Electronic address: zhaoweiqdfy@126.com. ; Jing Zhao:1.Department of Pathology, the Affiliated Hospital of Qingdao University, Qingdao, China. ; Kun Li:1.Department of Hepatobiliary and Pancreatic Surgery, the Affiliated Hospital of Qingdao University, Qingdao, China. ; Yanjiao Hu:1.Department of Pathology, the Affiliated Hospital of Qingdao University, Qingdao, China. ; Dongxia Yang:1.Department of Hepatobiliary and Pancreatic Surgery, the Affiliated Hospital of Qingdao University, Qingdao, China. ; Bin Tan:1.Department of Hepatobiliary and Pancreatic Surgery, the Affiliated Hospital of Qingdao University, Qingdao, China. ; Jian Shi:1.Department of Hepatobiliary and Pancreatic Surgery, the Affiliated Hospital of Qingdao University, Qingdao, China. ;

  期刊：Oncogenic Role of the NFATC2/NEDD4/FBP1 Axis in Cholangiocarcinoma

  DOI：10.1016/j.labinv.2023.100193

  影响因子 ：5.0

  引用产品： RBE 细胞 ,  HCCC-9810 细胞

• Identification of SPRYD4 as a tumour suppressor predicts prognosis and correlates with immune infiltration in cholangiocarcinoma (2023-05-04)

  作者：Zuyi Ma:1.Department of General Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, No. 1 Shuaifuyuan, Dongcheng District, Beijing, 100005, China. ; Tiange Xie:1.Department of General Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, No. 1 Shuaifuyuan, Dongcheng District, Beijing, 100005, China. ; Jia Sun:1.Department of General Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, No. 1 Shuaifuyuan, Dongcheng District, Beijing, 100005, China. ; Jianchun Yu:1.Department of General Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science a

  期刊：Identification of SPRYD4 as a tumour suppressor predicts prognosis and correlates with immune infiltration in cholangiocarcinoma

  DOI：10.1186/s12885-023-10810-9

  影响因子 ：3.8

  引用产品： HuCC-T1 细胞 ,  RBE 细胞 ,  CCLP-1 细胞 ,  huh28 细胞 ,  QBC939 细胞 ,  HCCC-9810 细胞

• Guanine nucleotide exchange factor T exerts the cancer-promoting function in cholangiocarcinoma by enhancing the Wnt-GSK-3β-β-catenin cascade via regulation of Rac1/Cdc42 (2023-03-26)

  作者：Xifang Wang:1.Department of Medical Oncology, Shaanxi Provincial People's Hospital, Xi'an 710068, China. ; Xiaomin Zhang:1.Department of Orthopaedics, Xi'an International Medical Center Hospital, Xi'an 710100, China. ; Jingying Sun:1.Shaanxi Provincial Key Laboratory of Infectious and Immunological Diseases, Shaanxi Provincial People's Hospital, Xi'an 710068, China. ; Yang Sun:1.Data Center, Shaanxi Provincial People's Hospital, s 710068, China. ; Yuan Zhang:1.Department of Medical Oncology, Shaanxi Provincial People's Hospital, Xi'an 710068, China. ; Li He:1.Department of Medical Oncology, Shaanxi Provincial People's Hospital, Xi'an 710068, China. ; Ping Wang:1.Department of Pathology, Shaanxi Provincial People's Hospital, Xi'an 710068, China. ; Feng Li:1.Department of Pathology and Medical Research Center, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China. Electronic address: li_feng7855@163.com. ; Chao Sun:1.Department of Medical Oncology, Shaanxi

  期刊：Guanine nucleotide exchange factor T exerts the cancer-promoting function in cholangiocarcinoma by enhancing the Wnt-GSK-3β-β-catenin cascade via regulation of Rac1/Cdc42

  DOI：10.1016/j.taap.2023.116492

  影响因子 ：3.8

  引用产品： 特级胎牛血清 ,  青霉素-链霉素溶液 (双抗)，100× ,  HCCC-9810 细胞 ,  人肝内胆管上皮细胞 ,  人肝内胆管上皮细胞完全培养基

• METTL3 promotes glycolysis and cholangiocarcinoma progression by mediating the m6A modification of AKR1B10 (2022-12-07)

  作者：Jingli Cai:1.Center of Gallbladder Disease, Shanghai East Hospital, Institute of Gallstone Disease, Tongji University School of Medicine, No. 150, Jimo Road, Pudong New Area, Shanghai, China. 417327108@qq.com. ; Zheng Cui:1.Department of Ultrasonic Medicine, Shanghai East Hospital, Institute of Gallstone Disease, Tongji University School of Medicine, Shanghai, China. ; Jingyi Zhou:1.Department of Oncology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. ; Bosen Zhang:1.Center of Gallbladder Disease, Shanghai East Hospital, Institute of Gallstone Disease, Tongji University School of Medicine, No. 150, Jimo Road, Pudong New Area, Shanghai, China. ; Ruiqi Lu:1.Center of Gallbladder Disease, Shanghai East Hospital, Institute of Gallstone Disease, Tongji University School of Medicine, No. 150, Jimo Road, Pudong New Area, Shanghai, China. ; Youcheng Ding:1.Center of Gallbladder Disease, Shanghai East Hospital, Institute of Gallstone Disease,

  期刊：METTL3 promotes glycolysis and cholangiocarcinoma progression by mediating the m6A modification of AKR1B10

  DOI：10.1186/s12935-022-02809-2

  影响因子 ：6.4

  引用产品： RBE 细胞 ,  HCCC-9810 细胞

• 7-Methoxy-13-dehydroxypaxilline: New indole diterpenoid from an endophytic fungus Penicillium sp. Nb 19 (2022-08-05)

  作者：Jing Yu:1.Yunnan Key Laboratory of Southern Medicine Utilization, Yunnan Branch Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences, Jinghong, China. ; Jia-Peng Wang:1.Yunnan Provincial Key Laboratory of Entomological Biopharmaceutical, College of Pharmacy, Dali University, Yunnan Dali, China. ; Shi-Fang Liu:1.Yunnan Key Laboratory of Southern Medicine Utilization, Yunnan Branch Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences, Jinghong, China. ; Cui-Yun Yin:1.Yunnan Key Laboratory of Southern Medicine Utilization, Yunnan Branch Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences, Jinghong, China. ; De-Ying Tang:1.Yunnan Key Laboratory of Southern Medicine Utilization, Yunnan Branch Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences, Jinghong, China. ; Yi-Hang Li:1.Yunnan Key Laboratory of Southern Medicine Utilization, Yunnan Branch Institute of Medicinal Plant Development,

  期刊：7-Methoxy-13-dehydroxypaxilline: New indole diterpenoid from an endophytic fungus Penicillium sp. Nb 19

  DOI：10.1080/14786419.2022.2107639

  影响因子 ：2.5

  引用产品： MCF7 [MCF-7] 细胞 ,  Hep G2 细胞 ,  HCCC-9810 细胞

• Circ_0000284 facilitates the growth, metastasis and glycolysis of intrahepatic cholangiocarcinoma through miR-152-3p-mediated PDK1 expression. (2022-11-04)

  作者：Jian Sun:1.Department II of General Surgery, Hanchuan People's Hospital, Hanchuan, Hubei, China. ; Menglong Feng:1.Department II of General Surgery, Hanchuan People's Hospital, Hanchuan, Hubei, China. ; Huilian Zou:1.Department of Gynaecology and Obstetrics, Hanchuan People's Hospital, Hanchuan, Hubei, China. ; Yanping Mao:1.Department II of General Surgery, Hanchuan People's Hospital, Hanchuan, Hubei, China. ; Wei Yu:1.Department II of General Surgery, Hanchuan People's Hospital, Hanchuan, Hubei, China. yuwei19811110@163.com. ;

  期刊：Circ_0000284 facilitates the growth, metastasis and glycolysis of intrahepatic cholangiocarcinoma through miR-152-3p-mediated PDK1 expression.

  DOI：10.14670/hh-18-544

  影响因子 ：2.1

  引用产品： RBE 细胞 ,  HCCC-9810 细胞 ,  人肝内胆管上皮细胞

• LncRNA MT1JP plays a protective role in intrahepatic cholangiocarcinoma by regulating miR-18a-5p/FBP1 axis (2002-01-20)

  作者：Wei Zhao:1.Department of Hepatopancreatobiliary Surgery, The Affiliated Hospital of Qingdao University, 1677 Wutaishan Road, Qingdao, 266000, People's Republic of China. zhaoweiqdfy@126.com. ; Jing Zhao:1.Department of Pathology, The Affiliated Hospital of Qingdao University, Qingdao, 266000, People's Republic of China. ; Xiao Guo:1.Heart Center, Qingdao Fuwai Cardiovascular Hospital, Qingdao, 266034, People's Republic of China. ; Yujie Feng:1.Department of Hepatopancreatobiliary Surgery, The Affiliated Hospital of Qingdao University, 1677 Wutaishan Road, Qingdao, 266000, People's Republic of China. ; Bingyuan Zhang:1.Department of Hepatopancreatobiliary Surgery, The Affiliated Hospital of Qingdao University, 1677 Wutaishan Road, Qingdao, 266000, People's Republic of China. ; Lantian Tian:1.Department of Hepatopancreatobiliary Surgery, The Affiliated Hospital of Qingdao University, 1677 Wutaishan Road, Qingdao, 266000, People's Republic of China. ;

  期刊：LncRNA MT1JP plays a protective role in intrahepatic cholangiocarcinoma by regulating miR-18a-5p/FBP1 axis

  DOI：10.1186/s12885-021-07838-0

  影响因子 ：3.8

  引用产品： HCCC-9810 细胞 ,  RBE 细胞

• Serum KIAA1199 is an advanced-stage prognostic biomarker and metastatic oncogene in cholangiocarcinoma (2011-00-20)

  作者：Xiangyu Zhai:1.Department of Surgery, School of Medicine, Cheeloo College of Medicine, Shandong University, Jinan, China. ; 2.Department of General Surgery, Qilu Hospital of Shandong University, Jinan, China. ; Wei Wang:1.Department of Surgery, School of Medicine, Cheeloo College of Medicine, Shandong University, Jinan, China. ; Yunlong Ma:1.Department of Surgery, School of Medicine, Cheeloo College of Medicine, Shandong University, Jinan, China. ; Yijia Zeng:1.Radiology Department, Qilu Hospital of Shandong University, Jinan, China. ; Dandan Dou:1.School of Basic Medical Sciences, Shandong University, Jinan, China. ; Haoning Fan:1.College of Traditional Chinese Medicine, Southern Medical University, Guangzhou, China. ; Jianping Song:1.Department of Surgery, School of Medicine, Cheeloo College of Medicine, Shandong University, Jinan, China. ; Xin Yu:1.School of Basic Medical Sciences, Shandong University, Jinan, China. ; Danqing Xin:1.School of Basic Medical Sciences, Shandong

  期刊：Serum KIAA1199 is an advanced-stage prognostic biomarker and metastatic oncogene in cholangiocarcinoma

  DOI：10.18632/aging.103964

  影响因子 ：5.2

  引用产品： HCCC-9810 细胞 ,  RBE 细胞

• Curcumol Exerts Anticancer Effect in Cholangiocarcinoma Cells via Down-Regulating CDKL3 (2003-08-20)

  作者：Jinduo Zhang:1.The First Clinical Medical College, Lanzhou University, Lanzhou, China. ; 2.Special Minimally Invasive Surgery, The First Hospital of Lanzhou University, Lanzhou, China. ; 3.School of Basic Medical Sciences, Institute of Genetics, Lanzhou University, Lanzhou, China. ; 4.Gansu Province Institute of Hepatopancreatobiliary, Lanzhou, China. ; 5.Gansu Province Key Laboratory Biotherapy and Regenerative Medicine, Lanzhou, China. ; Gang Su:1.The First Clinical Medical College, Lanzhou University, Lanzhou, China. ; 2.School of Basic Medical Sciences, Institute of Genetics, Lanzhou University, Lanzhou, China. ; Zengwei Tang:1.The First Clinical Medical College, Lanzhou University, Lanzhou, China. ; 2.Special Minimally Invasive Surgery, The First Hospital of Lanzhou University, Lanzhou, China. ; 3.Gansu Province Institute of Hepatopancreatobiliary, Lanzhou, China. ; 4.Gansu Province Key Laboratory Biotherapy and Regenerative Medicine, Lanzhou, China. ; Li Wang:1.School of Basic

  期刊：Curcumol Exerts Anticancer Effect in Cholangiocarcinoma Cells via Down-Regulating CDKL3

  DOI：10.3389/fphys.2018.00234

  影响因子 ：4.0

  引用产品： HCCC-9810 细胞

• Unique Responses of Hepatocellular Carcinoma and Cholangiocarcinoma Cell Lines toward Cantharidin and Norcantharidin (2005-08-20)

  作者：Qixiang Ma:1.School of Life Sciences, Centre For Translational Oncology, Beijing University of Chinese Medicine, 11 Beisanhuandong Road, Chaoyang District, Beijing 100029, People's Republic of China. ; Yanyan Feng:1.School of Life Sciences, Centre For Translational Oncology, Beijing University of Chinese Medicine, 11 Beisanhuandong Road, Chaoyang District, Beijing 100029, People's Republic of China. ; Kaiwen Deng:1.School of Life Sciences, Centre For Translational Oncology, Beijing University of Chinese Medicine, 11 Beisanhuandong Road, Chaoyang District, Beijing 100029, People's Republic of China. ; Haozhen Shao:1.School of Life Sciences, Centre For Translational Oncology, Beijing University of Chinese Medicine, 11 Beisanhuandong Road, Chaoyang District, Beijing 100029, People's Republic of China. ; Tongtong Sui:1.School of Life Sciences, Centre For Translational Oncology, Beijing University of Chinese Medicine, 11 Beisanhuandong Road, Chaoyang District, Beijing 100029, People's R

  期刊：Unique Responses of Hepatocellular Carcinoma and Cholangiocarcinoma Cell Lines toward Cantharidin and Norcantharidin

  DOI：10.7150/jca.25454

  影响因子 ：3.9

  引用产品： HCCC-9810 细胞 ,  RBE 细胞

点击展开收起列表